Company Number: 12929547

Analysis Date: 2025-07-29 17:39 UTC

1. Credit Opinion: DECLINE
   Dendrityca Ltd shows a persistently weak financial position with escalating current liabilities (£68,477 in 2024, up from £59,564 in 2023) far exceeding current assets (£3,697 in 2024). The company has negative net current assets and shareholders’ funds worsening over five years (£-63,484 in 2024 vs. £-15,088 in 2020). There is no evidence of profitability or cash generation to service debt, and no employees indicating limited operational scale. Given the negative equity and working capital deficits, the company lacks capacity to meet short-term obligations reliably, presenting high credit risk.

2. Financial Strength:
   The balance sheet reveals negative net assets of £63,482 as of 31 October 2024, deteriorating from prior years. Fixed assets are minimal (£1,298) and do not cover liabilities. The company’s equity is deeply negative, reflecting accumulated losses and ongoing funding shortfalls. This undercapitalization suggests an inability to absorb financial shocks or invest in growth. Lack of positive retained earnings and absence of debt amortization capacity are concerns. Overall, financial strength is very weak.

3. Cash Flow Assessment:
   Cash on hand is low and fluctuating, standing at £3,697 in 2024, insufficient relative to current liabilities. Debtors are negligible or nil, indicating poor cash inflows from customers. The significant negative net current assets (£-64,780) imply reliance on external financing or creditor forbearance to fund operations. No employees suggest limited business activity generating positive cash flows. Liquidity is severely constrained, raising concerns about ongoing operational viability without new capital injections.

4. Monitoring Points:

• Trend of current liabilities vs. current assets for further deterioration or improvement.
• Any evidence of revenue generation or cash inflows improving debt servicing capability.
• Changes in directors or ownership that might signal restructuring or recapitalization.
• Compliance with filing deadlines and potential disclosures indicating financial distress or turnaround plans.
• Presence of related party loans or contingent liabilities that could impact credit exposure.